Aspilia africana

Aspilia africana is an African medicinal plant containing flavonoids and phenolic compounds that exhibit anti-inflammatory properties. Research demonstrates its wound healing potential through modulation of inflammatory pathways and cellular repair mechanisms.

Origin & History

Aspilia africana is a medicinal herb from the Asteraceae family native to East Africa, distributed across tropical regions including Uganda, Tanzania, Congo, Nigeria, and Ghana, where it grows in farmlands, wastelands, and savanna forests. The plant is typically harvested for its leaves and stems, with extracts prepared through aqueous decoction or concentration via air-drying at 42°C, yielding preparations rich in sesquiterpenes, saponins, and polyphenolic compounds.

Historical & Cultural Context

Aspilia africana has been used for centuries across Eastern, Central, and Western African traditional medicine systems to treat inflammatory conditions, wounds, respiratory ailments, malaria, and diabetes. Its widespread traditional use across multiple African countries supports its ethnopharmacological importance, though clinical validation remains absent.

Health Benefits

• Anti-inflammatory effects demonstrated in animal models through reduction of paw edema and leukocyte recruitment (preliminary evidence only)
• Wound healing potential supported by in vitro and in vivo pharmacological studies (no human trials available)
• Traditional use for respiratory conditions including cough and tuberculosis (ethnopharmacological evidence only)
• Potential anticoagulant activity through prolongation of clotting times (in vitro plasma studies only)
• Traditional antimalarial and antidiabetic applications (no clinical validation available)

How It Works

Aspilia africana's flavonoids and phenolic compounds inhibit pro-inflammatory mediators including tumor necrosis factor-alpha and interleukin-1β, reducing leukocyte recruitment to inflammation sites. The plant's bioactive compounds promote wound healing by enhancing fibroblast proliferation and collagen synthesis while modulating the inflammatory phase of tissue repair.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Aspilia africana. Current evidence is limited to traditional use reports, in vitro studies, and animal models using rodents, with anti-inflammatory effects demonstrated through compounds like β-caryophyllene and phytol in rat paw edema models.

Clinical Summary

Current evidence for Aspilia africana is limited to preclinical studies, with no human clinical trials available. Animal studies demonstrate significant reduction in paw edema models of inflammation, with anti-inflammatory effects comparable to standard NSAIDs. In vitro wound healing assays show enhanced cell migration and proliferation rates. The evidence quality remains preliminary, requiring human studies to establish clinical efficacy and safety profiles.

Nutritional Profile

Aspilia africana (African Wild Marigold/Haemorrhage Plant) has limited formal nutritional analysis, but documented phytochemical composition includes: Bioactive compounds: thiarubrine-A (a dithiacyclohexadiene polyacetylene, ~0.1-0.5% dry weight in leaf tissue) identified as primary antimicrobial/antiparasitic constituent; flavonoids including quercetin, kaempferol, and luteolin glycosides (combined ~1.2-2.8% dry weight); tannins (~4.6-7.2% dry weight, primarily hydrolysable and condensed forms); saponins (~2.1-3.8% dry weight); alkaloids in trace quantities (~0.3-0.8% dry weight); phenolic acids including caffeic acid and chlorogenic acid derivatives (~0.9-1.6% dry weight). Terpenoids: sesquiterpene lactones and diterpenes present in leaf and stem fractions. Volatile essential oils (~0.2-0.6% fresh weight) containing alpha-pinene, beta-caryophyllene, and borneol. Proximate composition (per 100g dry leaf, limited data): crude protein approximately 12-18g; crude fiber approximately 18-24g; ash content approximately 8-12g indicating moderate mineral density; crude fat approximately 3-6g. Mineral content: iron relatively high (~180-320 mg/kg dry weight, supporting traditional hemostatic use); calcium (~8-15 g/kg dry weight); potassium (~12-22 g/kg dry weight); magnesium (~3-6 g/kg dry weight); zinc (~25-45 mg/kg dry weight). Chlorophyll a and b present in leaf fractions. Bioavailability note: tannin content may reduce mineral bioavailability, particularly iron and zinc, through chelation; thiarubrine-A is heat-labile and significantly degraded by boiling, reducing activity in decoction preparations compared to fresh plant or cold extracts.

Preparation & Dosage

No clinically studied dosage ranges are available for humans. Animal studies used aqueous leaf extracts at 0.5-1.0 g/kg/day orally in rats for 14 days, but these doses showed signs of ovarian toxicity and cannot be extrapolated to human use. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Turmeric, Boswellia, Ginger, White Willow Bark, Devil's Claw

Safety & Interactions

Safety data for Aspilia africana in humans is currently unavailable due to lack of clinical trials. Traditional use suggests general tolerability, but standardized toxicity studies have not been conducted. Potential interactions with anticoagulant medications may exist due to the plant's wound healing properties affecting clotting mechanisms. Pregnancy and breastfeeding safety cannot be established without proper human safety studies.